Alopecia Totalis and Alopecia Universalis - How is Alopecia Totalis and Alopecia Universalis abbreviated?
AT/AU (redirected from Alopecia Totalis and Alopecia Universalis)
|AT/AU||Alopecia Totalis and Alopecia Universalis (hair loss)|
References in periodicals archive
The United States Food and Drug Administration has approved the 30-day review period for US-based Aclaris Therapeutics' investigational new drug application for ATI-50001, an orally administered investigational Janus Kinase inhibitor, intended for the potential treatment of alopecia totalis and alopecia universalis
, it was reported on Thursdau.
60% patients were of extensive AA, and 20% each of alopecia totalis and alopecia universalis
The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis